The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
NF-κB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation
Cuzzocrea, S., Chatterjee, P. K., Mazzon, E., Dugo, L., Serraino, I., Britti, D., Mazzullo, G., Caputi, A. P., & Thiemermann, C. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704463 · Cited by 209
RetractedNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Evolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,605
Singh, R. P., Kurz, J., & Boiteau, G. (1996) · Journal of Virological Methods · doi:10.1016/0166-0934(96)02096-4 · Cited by 2,552
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., & Baltimore, D. (1995) · Nature · doi:10.1038/376167a0 · Cited by 1,825
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yamamoto, Y., & Gaynor, R. B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11914 · Cited by 1,585
Gene silencing in mammals by small interfering RNAs
McManus, M. T., & Sharp, P. A. (2002) · Nature Reviews Genetics · doi:10.1038/nrg908 · Cited by 1,399
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194
Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
Sha, W. C., Liou, H.-C., Tuomanen, E. I., & Baltimore, D. (1995) · Cell · doi:10.1016/0092-8674(95)90415-8 · Cited by 1,157
Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S. T., Weil, R., Agou, F., Kirk, H. E., Kay, R. J., & Israël, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81466-x · Cited by 1,076
Pelletier, J.-P., Martel-Pelletier, J., & Abramson, S. B. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1237::aid-art214>3.0.co;2-f · Cited by 1,072
A physical and functional map of the human TNF-α/NF-κB signal transduction pathway
Bouwmeester, T., Bauch, A., Ruffner, H., Angrand, P.-O., Bergamini, G., Croughton, K., Cruciat, C., Eberhard, D., Gagneur, J., Ghidelli, S., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1086 · Cited by 1,029
Series Introduction: The transcription factor NF-κB and human disease
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11891 · Cited by 990
The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways
Dejardin, E., Droin, N. M., Delhase, M., Haas, E., Cao, Y., Makris, C., Li, Z.-W., Karin, M., Ware, C. F., & Green, D. R. (2002) · Immunity · doi:10.1016/s1074-7613(02)00423-5 · Cited by 922
Therapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
NF-κB signaling pathways in mammalian and insect innate immunity
Silverman, N., & Maniatis, T. (2001) · Genes & Development · doi:10.1101/gad.909001 · Cited by 907
Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase
Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R., & Karin, M. (1999) · Science · doi:10.1126/science.284.5412.316 · Cited by 823
Vincenti, M. P., & Brinckerhoff, C. E. (2002) · Arthritis Research & Therapy · doi:10.1186/ar401 · Cited by 796
Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
Tegeder, I., Pfeilschifter, J., & Geisslinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0390rev · Cited by 747
Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B
Wahl, C., Liptay, S., Adler, G., & Schmid, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci992 · Cited by 742
IκB kinases: key regulators of the NF-κB pathway
Yamamoto, Y., & Gaynor, R. B. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.003 · Cited by 640
Limb and Skin Abnormalities in Mice Lacking IKKα
Takeda, K., Takeuchi, O., Tsujimura, T., Itami, S., Adachi, O., Kawai, T., Sanjo, H., Yoshikawa, K., Terada, N., & Akira, S. (1999) · Science · doi:10.1126/science.284.5412.313 · Cited by 609
Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression
Yamamoto, Y., Verma, U. N., Prajapati, S., Kwak, Y.-T., & Gaynor, R. B. (2003) · Nature · doi:10.1038/nature01576 · Cited by 577
Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice
Tanaka, M., Fuentes, M. E., Yamaguchi, K., Durnin, M. H., Dalrymple, S. A., Hardy, K. L., & Goeddel, D. V. (1999) · Immunity · doi:10.1016/s1074-7613(00)80042-4 · Cited by 569
Morpholino Oligos: Making Sense of Antisense?
Heasman, J. (2002) · Developmental Biology · doi:10.1006/dbio.2001.0565 · Cited by 533
Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice.
Rudolph, D., Yeh, W., Wakeham, A. C., Rudolph, B., Nallainathan, D., Potter, J., Elia, A., & Mak, T. W. (2000) · PubMed · Cited by 528
A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression
Anest, V., Hanson, J. L., Cogswell, P. C., Steinbrecher, K. A., Strahl, B. D., & Baldwin, A. S. (2003) · Nature · doi:10.1038/nature01648 · Cited by 522
Severe liver degeneration and lack of NF-κ B activation in NEMO/IKKγ-deficient mice
Rudolph, D., Yeh, W.-C., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A. J., & Mak, T. W. (2000) · Genes & Development · doi:10.1101/gad.14.7.854 · Cited by 479
Nuclear transcription factor-κB as a target for cancer drug development
Garg, A., & Aggarwal, B. (2002) · Leukemia · doi:10.1038/sj.leu.2402482 · Cited by 441
Transcriptional Activation by NF-κB Requires Multiple Coactivators
Sheppard, K.-A., Rose, D. W., Haque, Z. K., Kurokawa, R., McInerney, E., Westin, S., Thanos, D., Rosenfeld, M. G., Glass, C. K., & Collins, T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6367 · Cited by 434
Makarov, S. S. (2001) · Arthritis Research · doi:10.1186/ar300 · Cited by 412
Liacini, A., Sylvester, J., Li, W. Q., & Zafarullah, M. (2002) · Matrix Biology · doi:10.1016/s0945-053x(02)00007-0 · Cited by 403
Mor, A., Abramson, S. B., & Pillinger, M. H. (2005) · Clinical Immunology · doi:10.1016/j.clim.2004.12.009 · Cited by 399
Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes
Largo, R., Alvarez-Soria, M. A., Dı́ez-Ortego, I., Calvo, E., Sánchez-Pernaute, O., Egido, J., & Herrero-Beaumont, G. (2003) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(03)00028-1 · Cited by 386
AP-1 and NF-kB Regulation in Rheumatoid Arthritis and Murine Collagen-Induced Arthritis
Han, Z., Boyle, D. L., Manning, A. M., & Firestein, G. S. (1998) · Autoimmunity · doi:10.3109/08916939808995367 · Cited by 369
De Bosscher, K., Schmitz, M. L., Vanden Berghe, W., Plaisance, S., Fiers, W., & Haegeman, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13504 · Cited by 363
De Bosscher, K., Vanden Berghe, W., Vermeulen, L., Plaisance, S., Boone, E., & Haegeman, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.3919 · Cited by 335
Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B.
Frantz, B., Nordby, E. C., Bren, G., Steffan, N., Paya, C. V., Kincaid, R. L., Tocci, M. J., O'Keefe, S. J., & O'Neill, E. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06329.x · Cited by 334
Rheumatoid arthritis: regulation of synovial inflammation
Sweeney, S. E., & Firestein, G. S. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00259-0 · Cited by 318
Natural products as targeted modulators of the nuclear factor-κ B pathway
Bremner, P., & Heinrich, M. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778637 · Cited by 312
Liacini, A. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00180-0 · Cited by 310
Mass spectrometry and proteomics
Gygi, S. P., & Aebersold, R. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00121-6 · Cited by 291
Nuclear factor–k B in rheumatoid synovium. Localization of P50 and P65
Handel, M. L., Mcmorrow, L. B., & Gravallese, E. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381209 · Cited by 289
Molecular pathology and pathobiology of osteoarthritic cartilage
Aigner, T., & McKenna, L. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8400-3 · Cited by 284
Vitamin C Suppresses TNFα-Induced NFκB Activation by Inhibiting IκBα Phosphorylation
Cárcamo, J. M., Pedraza, A., Bórquez-Ojeda, O., & Golde, D. W. (2002) · Biochemistry · doi:10.1021/bi0263210 · Cited by 280
Kishore, N., Sommers, C., Mathialagan, S., Guzova, J., Yao, M., Hauser, S., Huynh, K., Bonar, S., Mielke, C., Albee, L., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211439200 · Cited by 272
De Bosscher, K. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00297-6 · Cited by 264
Loeser, R. F., Yammani, R. R., Carlson, C. S., Chen, H., Cole, A., Im, H., Bursch, L. S., & Yan, S. D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21199 · Cited by 243
Inhibitor of nuclear factor ?B kinase ? is a key regulator of synovial inflammation
Tak, P. P., Gerlag, D. M., Aupperle, K. R., Geest, D. A. V. D., Overbeek, M. J., Bennett, B. L., Boyle, D. L., Manning, A. M., & Firestein, G. S. (2001) · Arthritis & Rheumatism · Cited by 234
Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation
Hedbom, E., & Häuselmann, H. J. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8404-z · Cited by 229
Nuclear factor-κB: a friend or a foe in cancer?
Shishodia, S., & Aggarwal, B. B. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.026 · Cited by 228
Proteasome inhibition: a new anti-inflammatory strategy
Elliott, P. J., Zollner, T. M., & Boehncke, W.-H. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0422-2 · Cited by 221
Tomita, T., Takeuchi, E., Tomita, N., Morishita, R., Kaneko, M., Yamamoto, K., Nakase, T., Seki, H., Kato, K., Kaneda, Y., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199912)42:12<2532::aid-anr5>3.0.co;2-2 · Cited by 218
McIntyre, K. W., Shuster, D. J., Gillooly, K. M., Dambach, D. M., Pattoli, M. A., Lu, P., Zhou, X., Qiu, Y., Zusi, F. C., & Burke, J. R. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11131 · Cited by 217
Yilmaz, Z. B. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg004 · Cited by 214
Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway
Epinat, J.-C., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203218 · Cited by 211
Pulai, J. I., Chen, H., Im, H.-J., Kumar, S., Hanning, C., Hegde, P. S., & Loeser, R. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5781 · Cited by 204
Signal transduction and transcription factors in rheumatic disease
Firestein, G. S., & Manning, A. M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:4<609::aid-anr3>3.0.co;2-i · Cited by 198
Manna, S. K., Mukhopadhyay, A., & Aggarwal, B. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5962 · Cited by 186
Lianxu, C., Hongti, J., & Changlong, Y. (2006) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.10.009 · Cited by 181
Kim, S.-J., Hwang, S.-G., Shin, D. Y., Kang, S.-S., & Chun, J.-S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202862200 · Cited by 168
Defining and Assaying RNAi in Mammalian Cells
Huppi, K., Martin, S. E., & Caplen, N. J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.017 · Cited by 163
Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation
Meyer, S., Kohler, N. G., & Joly, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00930-7 · Cited by 161
Agarwal, S., Deschner, J., Long, P., Verma, A., Hofman, C., Evans, C. H., & Piesco, N. P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20601 · Cited by 160
Séguin, C. A., & Bernier, S. M. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10371 · Cited by 147
Signal transduction in rheumatoid arthritis
Sweeney, S. E., & Firestein, G. S. (2004) · Current Opinion in Rheumatology · doi:10.1097/00002281-200405000-00011 · Cited by 135
NF-κB Regulation by IκB Kinase-2 in Rheumatoid Arthritis Synoviocytes
Aupperle, K. R., Bennett, B. L., Han, Z., Boyle, D. L., Manning, A. M., & Firestein, G. S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2705 · Cited by 131
Forsyth, C. B., Cole, A. A., Murphy, G., Bienias, J. L., Im, H.-J., & Loeser, R. F. (2005) · The Journals of Gerontology Series A · doi:10.1093/gerona/60.9.1118 · Cited by 125
Signal transduction by mechanical strain in chondrocytes
Deschner, J., Hofman, C., Piesco, N. P., & Agarwal, S. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000068964.34812.2b · Cited by 109
Molecular mechanisms of corticosteroid actions
Payne, D., & Adcock, I. M. (2001) · Paediatric Respiratory Reviews · doi:10.1053/prrv.2000.0122 · Cited by 104
Quantitative prediction of NF-κB DNA– protein interactions
Udalova, I. A., Mott, R., Field, D., & Kwiatkowski, D. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102674699 · Cited by 103
FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells.
Venkataraman, L., Burakoff, S. J., & Sen, R. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1091 · Cited by 90
NF‐κB: Holy Grail for rheumatoid arthritis?
Firestein, G. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20468 · Cited by 89
Is NF-κB a useful therapeutic target in rheumatoid arthritis?
Feldmann, M., Andreakos, E., Smith, C., Bondeson, J., Yoshimura, S., Kiriakidis, S., Monaco, C. G., Gasparini, C., Sacre, S. M., Lundberg, A. M., et al. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii13 · Cited by 87
Nitric oxide sustains nuclear factor kappaB activation in cytokine-stimulated chondrocytes
Clancy, R. M., Gomez, P., & Abramson, S. B. (2004) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2004.04.003 · Cited by 86
Agarwal, S., Long, P., al., S. B. E. A. S. B. E., Piesco, N. P., Shree, A., & Gassner, R. J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0901fje · Cited by 83
Molecular imaging of the transcription factor NF-κB, a primary regulator of stress response
Carlsen, H., Alexander, G., Austenaa, L. M. I., Ebihara, K., & Blomhoff, R. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.02.024 · Cited by 82
Benito, M. J., Murphy, E., Murphy, E. P., van den Berg, W. B., FitzGerald, O., & Bresnihan, B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20260 · Cited by 79
LNA-antisense rivals siRNA for gene silencing.
Stenvang, J., & Wengel, J. (2004) · PubMed · Cited by 75
New targets for anti-inflammatory drugs
Lewis, A. J., & Manning, A. M. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80071-4 · Cited by 74
The Effect of Dexamethasone on the Expression of Activated NF-κB in Adjuvant Arthritis
Tsao, P. W., Suzuki, T., Totsuka, R., Murata, T., Takagi, T., Ohmachi, Y., Fujimura, H., & Takata, I. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4333 · Cited by 74
IL-1β Protects Human Chondrocytes from CD95-Induced Apoptosis
Kühn, K., Hashimoto, S., & Lotz, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2233 · Cited by 70
Mendes, A. F., Caramona, M. M., Carvalho, A. P., & Lopes, M. C. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.910104.x · Cited by 68
Osteoarthritis--an inflammatory disease?
Katona, G. (1984) · PubMed · Cited by 64
Martin, G., Andriamanalijaona, R., Grässel, S., Dreier, R., Mathy-Hartert, M., Bogdanowicz, P., Boumédiene, K., Henrotin, Y. E., Brückner, P., & Pujol, J. ‐. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20596 · Cited by 59
Regulation of CD95 (Fas/APO-1)-induced apoptosis in human chondrocytes
K�hn, K., & Lotz, M. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1644::aid-art287>3.0.co;2-s · Cited by 57
Fujihara, S. M., Cleaveland, J. S., Grosmaire, L. S., Berry, K. K., Kennedy, K. A., Blake, J., Loy, J. K., Rankin, B. M., Ledbetter, J. A., & Nadler, S. G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1004 · Cited by 56
Relić, B., Bentires‐Alj, M., Ribbens, C., Franchimont, N., Guerne, P., Benoît, V., Merville, M., Bours, V., & Malaise, M. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000041714.05322.c0 · Cited by 47
Kim, S. J., & Chun, J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00305-x · Cited by 44
Blackwell, N. M., Sembi, P., Newson, J., Lawrence, T., Gilroy, D. W., & Kabouridis, P. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20467 · Cited by 42
Inhibition of NF-κB mediated inflammation by siRNA expressed by recombinant adeno-associated virus
Pinkenburg, O., Platz, J., Beißwenger, C., Vogelmeier, C. F., & Bals, R. (2004) · Journal of Virological Methods · doi:10.1016/j.jviromet.2004.04.007 · Cited by 38
Gene deletion of NF-κB p50 does not alter the hepatic inflammatory response to ischemia/reperfusion
Kato, A., Edwards, M. J., & Lentsch, A. B. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00068-5 · Cited by 38
Calfee-Mason, K. G., Spear, B. T., & Glauert, H. P. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.03.006 · Cited by 33
Regulation of NF-κB/Rel by IκB is essential for ascidian notochord formation
Kawai, N., Takahashi, H., Nishida, H., & Yokosawa, H. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.09.007 · Cited by 20
Handel, M. L., & Girgis, L. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0186 · Cited by 19
Research works printed but not linked: 9
- Scheidereit, 1996, Transcription factors: important tools and targets for molecular medicine, J Mol Med, 74, 707, 10.1007/s001090050075 · doi:10.1007/s001090050075
- Eguchi, 2002, NF-kappa B and I-kappa B overexpression in articular chondrocytes with progression of type II collagen-induced arthritis in DBA/1 mouse knees, Clin Exp Rheumatol, 20, 647
- Kim, 2002, TNF-alpha-mediated apoptosis in chondrocytes sensitized by MG132 or actinomycin D, Biochem Biophys Res Commun, 295, 937, 10.1016/S0006-291X(02)00789-1 · doi:10.1016/s0006-291x(02)00789-1
- Su, 1991, Activation of transcription factor NF kappa B in Jurkat cells is inhibited selectively by FK 506 in a signal-dependent manner, Transplant Proc, 23, 2912
- Cuschieri, 2004, Implications of proteasome inhibition: an enhanced macrophage phenotype, Cell Immunol, 227, 140, 10.1016/j.cellimm.2004.03.005 · doi:10.1016/j.cellimm.2004.03.005
- Meierhofer, 2003, New insights into the pharmacological and toxicological effects of thalidomide, Curr Opin Drug Discov Devel, 6, 92
- Bacher, 2004, The NF-kappaB pathway as a potential target for autoimmune disease therapy, Curr Pharm Des, 10, 2827, 10.2174/1381612043383584 · doi:10.2174/1381612043383584
- Kawakami, 1999, Regulation of synovial cell apoptosis by proteasome inhibitor, Arthritis Rheum, 42, 2440, 10.1002/1529-0131(199911)42:11<2440::AID-ANR23>3.0.CO;2-0 · doi:10.1002/1529-0131(199911)42:11<2440::aid-anr23>3.0.co;2-0
- Hashimoto, 2003, NF-κB decoy oligodeoxynucleotides suppressed the progression of osteoarthritis in rat arthritis, Arthritis Rheum, 48, S630
Cited by
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.-P., & Fahmi, H. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.196 · Cited by 2,778
The Role of Inflammatory and Anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis
Wojdasiewicz, P., Poniatowski, Ł. A., & Szukiewicz, D. (2014) · Mediators of Inflammation · doi:10.1155/2014/561459 · Cited by 1,608
NF-κB Signaling: Multiple Angles to Target OA
B. Marcu, K., Otero, M., Olivotto, E., Maria Borzi, R., & B. Goldring, M. (2010) · Current Drug Targets · doi:10.2174/138945010791011938 · Cited by 565
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Role of Thyroid Hormones in Skeletal Development and Bone Maintenance
Bassett, J. H. D., & Williams, G. R. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1106 · Cited by 540
Metadata
- Authors
- Roman-Blas, J. A., & Jimenez, S. A.
- Venue
- Osteoarthritis and Cartilage
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 14
- Issue
- 9
- Pages
- 839-848
- ISSN
- 1063-4584 (ISSN-L)
- OpenAlex
- W2010802338
- Cited by
- 688
- References
- 100
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2726 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.